Thrombopoietin receptor agonist
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Thrombopoietin receptor agonist, covering 2024-06-28 to 2025-02-24. Get the full timeline:
Most recent: Clinical Trial Update: TPO-RA in Primary Immune Thrombocytopenia (ITP) in Patients Older Than 14 Years [NA]